KEY FINDINGS The Europe neurovascular devices / interventional neurology market growth is anticipated to progress at a CAGR of 4.87% during the forecast period, 2021-2028. The surging prevalence of neurovascular diseases boosts the market growth. For instance, there will be a 34% increase in stroke incidences between 2015 and 2035, as per the Stroke Alliance for Europe.
MARKET INSIGHTS Poland, Italy, the United Kingdom, Germany, Belgium, Russia, France, and Rest of Europe, are evaluated for the Europe neurovascular devices / interventional neurology market growth analysis.Germany has a world-class healthcare system that offers cost-effective treatment.
As per The Burden of Stroke in Europe report by the King’s College, London, the stroke incidence rate is 51.7 per 100,000 in the country. Also, Germany has a considerable mortality rate due to stroke, with almost 75,861 deaths annually. With an expectant increase in such incidences, the demand for neurovascular diseases is projected to increase during the forecast period. In Italy, the healthcare system is witnessing growth with developments in neurology.As per the XLVII Congress of the Italian Society of Neurology’s report, more than 1 million have dementia.
Every year 120,000 people are affected by stroke, and another 930,000 are affected by the disability caused by stroke.Also, Italy has a growing senior population, contributing to increasing cases of neurological disorders like Parkinson’s disease and multiple sclerosis.
In Spain, stroke is the third leading cause of death after Alzheimer’s disease and ischemic heart stroke.Also, the government has increased its investment in healthcare systems.
Such factors facilitate market growth in these countries.
COMPETITIVE INSIGHTS Some of the eminent firms in the market are B Braun Melsungen AG, Phenox GmbH, Rapid Medical, Microport Scientific Corporation, Kaneka Corporation, etc.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned 1. ACANDIS GMBH 2. ASAHI INTECC 3. BALT 4. B BRAUN MELSUNGEN AG 5. INTEGER HOLDINGS CORPORATION 6. JOHNSON & JOHNSON (CERENOVUS) 7. KANEKA CORPORATION 8. MEDTRONIC INC 9. MEMRY CORPORATION 10. MICROPORT SCIENTIFIC CORPORATION 11. PENUMBRA INC 12. PHENOX GMBH 13. RAPID MEDICAL 14. SENSOME 15. STRYKER CORPORATION 16. TERUMO MEDICAL CORPORATION (MICROVENTION INC)
Our reports have been used by over 10K customers, including:
KEY FINDINGS The China neurovascular devices / interventional neurology market is estimated to record a CAGR of 5.22% during the forecast period, 2021-2026. The surging elderly population and the increasing R&D activities in neuro therapies are the key factors driving the market growth. MARKET INSIGHTS The...
The global wearable injectors market is projected to reach USD 11.5billion by 2026 from USD 7.2billion in 2021, at a CAGR of 9.9% during the forecast period. Growth in this market is mainly driven by factors such as the shift of healthcare delivery toward homecare due to COVID-19, advantages of wearable injectors in the administration of various...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
KEY FINDINGS The Europe oxygenators market is projected to develop with a CAGR of 5.27% over the forecast period of 2021 to 2028. Chief factors such as the surging healthcare expenditure, the increasing need for medical devices, the growing public and private investment in research and development, and the prevalence of...
Europe specialty generics market reached a value of US$ 16.4 Billion in 2020. Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic...
The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of...
KEY FINDINGS The Europe X-ray detector market is anticipated to record a CAGR of 6.28% during the forecasted period of 2021 to 2028. Some of the key factors, like the rising cases of accidents and injuries, the increasing incidence of chronic conditions, the growing geriatric populace, and the high prevalence of cancer...
17 pages •
By Euromonitor International
• Aug 2021
After reaching a peak in 2031, Finland’s population is set to decline up to 2040 as rates of natural decrease rise. Ageing will be a key trend over this timeframe, resulting in a transformation of consumer trends. Urbanisation will continue to be rapid, with Espoo being the fastest growing city. Despite, its shrinking population, Finland should...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
In Vitro Diagnostic Reagent
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.